CLINICAL_TRIALS
trial_result
· 2022-02-21
Clinical Trial Update: Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles [Phase 4]
Summary
Phase 4 trial update on booster dose of hCG for luteinised unruptured follicle syndrome in non-IVF/ICSI cycles has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: LUF - Luteinised Unruptured Follicle Syndrome | Phase 4 | Status: COMPLETED